Scotia Capital Inc. Atri Cure, Inc. Transaction History
Scotia Capital Inc.
- $17.6 Billion
- Q1 2025
A detailed history of Scotia Capital Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Scotia Capital Inc. holds 36,609 shares of ATRC stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,609Holding current value
$1.27 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$164 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$160 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$128 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$104 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$84.6 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.61B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...